- Automated CRP Test for professional use in primary and community care, patient home and hospital emergency care settings to aid in the assessment of infection, tissue injury, and inflammatory ...

The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in ...

Background: Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary antibiotic prescribing in respiratory tract infections (RTI), but its use in primary ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a ...

Researchers from the United Kingdom found that the C-reactive protein (CRP) finger-prick blood test resulted in significantly fewer people using antibiotics for chronic obstructive pulmonary disease ...

DUBLIN, March 11, 2020 /PRNewswire/ -- The "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report by Assay Type, by Detection Range, by Disease Area (Cancer, Endometriosis, ...

DUBLIN--(BUSINESS WIRE)--The "C-reactive Protein Testing Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The major factors propelling ...

Please provide your email address to receive an email when new articles are posted on . Antibiotic prescribing in primary care practice for patients with COPD exacerbations is generally based on ...

Many cardiologists are on the fence about whether to test patients routinely for C-reactive protein (CRP), a marker for arterial inflammation. Proponents say CRP blood levels are at least as good at ...